Clinical Research Directory
Browse clinical research sites, groups, and studies.
Salivary microRNA in Endometriosis: Correlation With Response to Progestin Therapy
Sponsor: University of Udine
Summary
This study aims to analyze the salivary miRNA specific for patients diagnosed with endometriosis, specifically evaluating the miRNA profile of patients who respond versus those who do not respond to progestin therapy. Ninety patients attending the Chronic Pelvic Pain Clinic will be recruited, and they will be asked to provide a saliva sample before starting medical therapy. The response to the therapy will be evaluated after 4 months from the beginning of the therapy itself.
Official title: Salivary MicroRNA in Endometriosis: Correlation With Progestin Treatment Response: A Prospective Observational Study
Key Details
Gender
FEMALE
Age Range
18 Years - 45 Years
Study Type
OBSERVATIONAL
Enrollment
90
Start Date
2024-04-22
Completion Date
2025-12-01
Last Updated
2025-04-02
Healthy Volunteers
No
Conditions
Interventions
Dienogest 2 MG
The patients will be started on progestin therapy after a saliva sample is collected from them for miRNA analysis.
Locations (1)
University of Udine
Udine, UD, Italy